| Mr Ronnie Santiago Mangulabnan Jr, | |
|
44 Old Ridgefield Rd Ste 213, Wilton, CT 06897-3014 | |
| (877) 407-3422 | |
| Not Available |
| Full Name | Mr Ronnie Santiago Mangulabnan Jr |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 15 Years |
| Location | 44 Old Ridgefield Rd Ste 213, Wilton, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174929848 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 009865 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fox Rehab Pt Ct, Llc | 8820235575 | 58 |
News Archive
Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that the National Institutes of Health ("NIH") has awarded a $2.87 million grant to fund the pre clinical development of a Ceragenin™based oral drug to treat two common and potentially deadly gastrointestinal infections: Clostrdium difficile and Shigella.
NovaSterilis Inc., a developer of supercritical carbon dioxide technology, has been granted US Patent 8,012,414 B2. The patent, dated September 6, 2011 entitled "Sterilization of Drugs Using Supercritical Carbon Dioxide Sterilant", covers a new and effective method of sterilizing pharmaceutical product without dangerous chemicals or radiation.
LifeNet Health, a leading allograft bio-implant company, announces the first implant of a CardioGraft(TM) allograft cardiac patch product with MatrACELL(TM)( )decellularization technology. The surgery was performed at Children's Mercy Hospital in Kansas City, Mo by Gary K. Lofland, MD, FACS, Section Chief, Cardiovascular Surgery at Children's Mercy Hospital in Kansas City, Mo, The Joseph Boon Gregg/Missouri Endowed Chair in Pediatric Cardiac Surgery, Professor of Surgery, UMKC.
The Texas Center for Quality & Patient Safety announced today that Blue Cross and Blue Shield of Texas is continuing its support for the TCQPS with a $150,000 donation to study and improve patient safety, including reduction of hospital readmissions and hospital-acquired infections.
The oral direct thrombin inhibitor dabigatran is an effective thromboprophylactic therapy for patients undergoing total hip or knee replacement regardless of their body mass index, researchers assert.
› Verified 5 days ago
| Provider Name | Fox Rehab Pt Ct, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1245584234 PECOS PAC ID: 8820235575 Enrollment ID: O20130516000426 |
News Archive
Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that the National Institutes of Health ("NIH") has awarded a $2.87 million grant to fund the pre clinical development of a Ceragenin™based oral drug to treat two common and potentially deadly gastrointestinal infections: Clostrdium difficile and Shigella.
NovaSterilis Inc., a developer of supercritical carbon dioxide technology, has been granted US Patent 8,012,414 B2. The patent, dated September 6, 2011 entitled "Sterilization of Drugs Using Supercritical Carbon Dioxide Sterilant", covers a new and effective method of sterilizing pharmaceutical product without dangerous chemicals or radiation.
LifeNet Health, a leading allograft bio-implant company, announces the first implant of a CardioGraft(TM) allograft cardiac patch product with MatrACELL(TM)( )decellularization technology. The surgery was performed at Children's Mercy Hospital in Kansas City, Mo by Gary K. Lofland, MD, FACS, Section Chief, Cardiovascular Surgery at Children's Mercy Hospital in Kansas City, Mo, The Joseph Boon Gregg/Missouri Endowed Chair in Pediatric Cardiac Surgery, Professor of Surgery, UMKC.
The Texas Center for Quality & Patient Safety announced today that Blue Cross and Blue Shield of Texas is continuing its support for the TCQPS with a $150,000 donation to study and improve patient safety, including reduction of hospital readmissions and hospital-acquired infections.
The oral direct thrombin inhibitor dabigatran is an effective thromboprophylactic therapy for patients undergoing total hip or knee replacement regardless of their body mass index, researchers assert.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Ronnie Santiago Mangulabnan Jr, 44 Old Ridgefield Rd Ste 213, Wilton, CT 06897-3014 Ph: () - | Mr Ronnie Santiago Mangulabnan Jr, 44 Old Ridgefield Rd Ste 213, Wilton, CT 06897-3014 Ph: (877) 407-3422 |
News Archive
Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that the National Institutes of Health ("NIH") has awarded a $2.87 million grant to fund the pre clinical development of a Ceragenin™based oral drug to treat two common and potentially deadly gastrointestinal infections: Clostrdium difficile and Shigella.
NovaSterilis Inc., a developer of supercritical carbon dioxide technology, has been granted US Patent 8,012,414 B2. The patent, dated September 6, 2011 entitled "Sterilization of Drugs Using Supercritical Carbon Dioxide Sterilant", covers a new and effective method of sterilizing pharmaceutical product without dangerous chemicals or radiation.
LifeNet Health, a leading allograft bio-implant company, announces the first implant of a CardioGraft(TM) allograft cardiac patch product with MatrACELL(TM)( )decellularization technology. The surgery was performed at Children's Mercy Hospital in Kansas City, Mo by Gary K. Lofland, MD, FACS, Section Chief, Cardiovascular Surgery at Children's Mercy Hospital in Kansas City, Mo, The Joseph Boon Gregg/Missouri Endowed Chair in Pediatric Cardiac Surgery, Professor of Surgery, UMKC.
The Texas Center for Quality & Patient Safety announced today that Blue Cross and Blue Shield of Texas is continuing its support for the TCQPS with a $150,000 donation to study and improve patient safety, including reduction of hospital readmissions and hospital-acquired infections.
The oral direct thrombin inhibitor dabigatran is an effective thromboprophylactic therapy for patients undergoing total hip or knee replacement regardless of their body mass index, researchers assert.
› Verified 5 days ago
Jennifer Smith, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 64 Danbury Rd, Wilton, CT 06897 Phone: 800-278-0332 | |
Professional Orthopedic And Sports Physical Therapy, P.c. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 37 Danbury Rd, Wilton, CT 06897 Phone: 203-307-4600 Fax: 203-307-4601 | |
Moore Center For Rehabilitation Of Wilton, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 37 Danbury Road, Wilton, CT 06897 Phone: 203-762-2900 | |
Lindsay Dakin, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 64 Danbury Rd, Wilton, CT 06897 Phone: 800-278-0332 | |
Chiropractic Health Center Of Wilton Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 126 Pimpewaug Rd, Wilton, CT 06897 Phone: 203-834-1515 Fax: 203-762-7210 | |
Jordan Helman, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 64 Danbury Rd Ste 100, Wilton, CT 06897 Phone: 800-278-0332 | |
Mrs. Siri M. Parsons, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 345 Belden Hill Rd, Wilton, CT 06897 Phone: 203-249-4526 |